Kolexia
Marot Stephane
Biologie médicale
Hôpital Pitie Salpetriere
Paris, France
82 Activités
295 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} COVID-19 Infections à coronavirus Pneumopathie virale Maladie grave Infections à VIH Syndrome respiratoire aigu sévère Urgences Orthopoxvirose simienne Myocardite

Industries

MSD
1 collaboration(s)
Dernière en 2017
{{person.topindus2.name}}
{{person.topindus2.tot}} collaboration(s)
Dernière en {{person.topindus2.last}}
{{person.topindus3.name}}
{{person.topindus3.tot}} collaboration(s)
Dernière en {{person.topindus3.last}}
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Seroprevalence of Crimean-Congo hemorrhagic fever virus among people living with HIV in Brazzaville, Congo and among blood donors in Bamako, Mali.
Ticks and tick-borne diseases   13 novembre 2023
Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study.
The Journal of infectious diseases   13 novembre 2023
COVID-19 early curative treatments in kidney transplant recipients: is it really reasonable at the Omicron era?
Nephrologie & therapeutique   03 novembre 2023
Comparative Performance of Anyplex II HPV28 and Cobas 4800 Human Papillomavirus (HPV) Assays for High-Risk HPV Detection in Self-collected Anal Samples.
Open forum infectious diseases   31 octobre 2023
Anal Monkeypox Disease: Description of 65 Cases.
Diseases of the colon and rectum   23 octobre 2023
In-hospital mortality of older patients with COVID-19 throughout the epidemic waves in the great Paris area: a multicenter cohort study.
BMC geriatrics   18 septembre 2023
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study.
Intensive care medicine experimental   07 août 2023
Three to four mRNA COVID-19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization.
European journal of neurology   25 juin 2023
Complement-dependent mpox-virus-neutralizing antibodies in infected and vaccinated individuals.
Cell host & microbe   05 mai 2023
Corrigendum: XAV-19, a swine glyco-humanized polyclonal antibody against SARS-CoV-2 spike receptor-binding domain, targets multiple epitopes and broadly neutralizes variants.
Frontiers in immunology   28 avril 2023